ArticleJournal of diabetes investigation2023
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes.
Erratum issuedAbstract readConsensus Statement
In one paragraph
Article in Journal of diabetes investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- Durability and Safety of Imeglimin as an Add-On to DPP-4 Inhibitors in Japanese Type 2 Diabetes: The 104-Week FAMILIAR Trial.Diabetes, obesity & metabolism · 2026Trial
- Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring.Journal of diabetes investigation · 2024Trial
- Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes.Journal of diabetes investigation · 2024Trial
- Treatment Selection Patterns and Associated Outcomes for Biguanides and SGLT2 Inhibitors in Type 2 Diabetes: A Retrospective Database Study in Japan.Drugs - real world outcomes · 2026Article
- Genetic basis of Asian diabetes.Journal of diabetes investigation · 2026Review
- Nonlinear modeling of health checkup factors and future claims-based healthcare costs in Japan: a retrospective cohort study.Health economics review · 2026Article
- Contemporary Type 2 Diabetes Guidelines: Converging Evidence, Diverging Strategies, and the Position of the Korean Diabetes Association Framework.Endocrinology and metabolism (Seoul, Korea) · 2026Review
- Impact of renal function on antidiabetic drug selection in Japan: A real-world analysis using the J-DREAMS database.Journal of diabetes investigation · 2026Article
- Metformin enhances survival with immune checkpoint inhibitors in cancer patients: A meta-analysis.Oncology letters · 2026Article
- Retrospective real-world database study to examine the prevalence and incidence of cardiovascular diseases and medication prescription in Japanese patients with type 2 diabetes.Diabetology international · 2026Article
- Association between metformin use and cervical cancer risk in women with diabetes in Japan: a retrospective cohort study.Annals of clinical epidemiology · 2026Article
- Hypoglycemia-Related Hospitalization in Adults with Type 2 Diabetes Receiving Insulin in Japan: Real-World Analysis Using the Medical Data Vision Database.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025Article
- A multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (PIONEER REAL Japan): Subgroup analyses.Journal of diabetes investigation · 2025Article
- Clinical use and monitoring of adverse effects of sodium-glucose cotransporter-2 inhibitors in persons with type 1 diabetes mellitus.Journal of diabetes investigation · 2025Article
- Transitional changes in medication-initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes-A hospital-based cohort study in Japan.Diabetes, obesity & metabolism · 2025Article
- Simultaneous Evaluation of Shear Wave Elastography and C-Peptide Index for Predicting Need of Insulin Therapy in Type 2 Diabetes: A Pilot Study.Journal of personalized medicine · 2025Article
- Myricetin Amplifies Glucose-Stimulated Insulin Secretion via the cAMP-PKA-Epac-2 Signaling Cascade.Biomedicines · 2025Article
- Cost-Effectiveness Analysis of SGLT2 Inhibitors for Cardio-Renal-Metabolic Disease Based on Data from Japanese Studies.Advances in therapy · 2025Article
- Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025Article
- Burden of Current Insulin Therapy and Expectations for Future Insulin Therapy: Results from INBEING, a Web-Based Survey in Japan.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024Article
Corrections and comments
- Erratum issuedErratum.2023
Authors and funding
13 authors.
Ryotaro BouchiDiabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID 0000-0002-7664-4342
Tatsuya KondoDepartment of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Kumamoto, Japan.ORCID 0000-0003-4830-8955
Yasuharu OhtaDivision of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Japan.ORCID 0000-0002-9117-6874
Atsushi GotoDepartment of Health Data Science, Graduate School of Data Science, Yokohama City University, Yokohama, Japan.ORCID 0000-0003-0669-654X
Daisuke TanakaDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hiroaki SatohDepartment of Diabetes and Endocrinology, Juntendo University Urayasu Hospital, Urayasu, Japan.ORCID 0000-0002-0353-5807
Daisuke YabeDepartment of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.
Rimei NishimuraDivision of Diabetes, Metabolism and Endocrinology, Jikei University School of Medicine, Tokyo, Japan.
Norio HaradaDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0001-8720-1013
Hideki KamiyaDivision of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
Ryo SuzukiDepartment of Diabetes, Metabolism and Endocrinology, Tokyo Medical University, Tokyo, Japan.ORCID 0000-0002-2965-6906
Toshimasa YamauchiDepartment of Diabetes and Metabolic Diseases, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
JDS Committee on Consensus Statement Development
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes Mellitus, Type 2AlgorithmsHumansHypoglycemic AgentsJapanSocieties, MedicalHypoglycemic AgentsAlgorithmPharmacotherapyType 2 diabetes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.